SCHEMBL7662068

SCHEMBL7662068

OCC(CO)CNCc1ccc(CNCC(CO)CO)nc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CXCR4 P61073 1/20 0.43
▸ PNP P00491 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ LMNA P02545 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ CD274 Q9NZQ7 3/20 0.34
▸ PDCD1 Q15116 2/20 0.34
▸ GAA P10253 1/20 0.34
▸ OPRM1 P35372 1/20 0.32
▸ OPRK1 P41145 1/20 0.32
▸ OXTR P30559 1/20 0.32
▸ AVPR1A P37288 1/20 0.32
▸ ALDH1A1 P00352 2/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ ADRB2 P07550 1/20 0.31
▸ CYP1A2 P05177 2/20 0.31
▸ CYP2D6 P10635 2/20 0.31
▸ DNM1 Q05193 1/20 0.31
▸ ANPEP P15144 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7657692 0.85 CD274 (0.46) CXCR4PNPKDM4ELMNAMEN1
SCHEMBL7654878 0.84 CXCR4 (0.41) CXCR4PNPKDM4ELMNAMEN1
SCHEMBL7104789 0.82 PNP (0.41) PNPKDM4EMEN1KMT2A
SCHEMBL7662084 0.77 CXCR4 (0.52) CXCR4LMNAMEN1KMT2ACD274
SCHEMBL7663658 0.72 CXCR4 (0.35) CXCR4PNPCD274PDCD1ALDH1A1
SCHEMBL7106463 0.72 PNP (0.36) PNP
SCHEMBL7663595 0.72 TRPV3 (0.44) CXCR4PNPKDM4ENPSR1DNM1
SCHEMBL7663573 0.72 PNP (0.36) PNPALDH1A1NPSR1ADRB2CYP1A2
SCHEMBL30707740 0.70 LMNA (0.42) CXCR4KDM4ELMNAMEN1KMT2A
SCHEMBL23529999 0.69 CXCR4 (0.38) CXCR4LMNAMEN1KMT2ACD274

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6399613-B1 N,N'-BIS(2-HYDROXYETHYL)PYRAZINE-2,5- OR -2,6-DICARBOXAMIDE; DIABETES AVENTIS PHARMA S.A. (FR) 2002-06-04 — — US claimed
US-6399613-B1 N,N'-BIS(2-HYDROXYETHYL)PYRAZINE-2,5- OR -2,6-DICARBOXAMIDE; DIABETES AVENTIS PHARMA S.A. (FR) 2002-06-04 — — US disclosed
Send feedback